DK249389A - 2-acylamino-benzothiazol-forbindelser og deres anvendelse til fremstilling af laegemidler til behandling af tumorer - Google Patents

2-acylamino-benzothiazol-forbindelser og deres anvendelse til fremstilling af laegemidler til behandling af tumorer Download PDF

Info

Publication number
DK249389A
DK249389A DK249389A DK249389A DK249389A DK 249389 A DK249389 A DK 249389A DK 249389 A DK249389 A DK 249389A DK 249389 A DK249389 A DK 249389A DK 249389 A DK249389 A DK 249389A
Authority
DK
Denmark
Prior art keywords
acylamino
manufacture
medicinal treatments
benzothiazol
compounds
Prior art date
Application number
DK249389A
Other languages
Danish (da)
English (en)
Other versions
DK249389D0 (da
Inventor
Anton Franz Josef Fliri
Rodney Caughren Schnur
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK249389D0 publication Critical patent/DK249389D0/da
Publication of DK249389A publication Critical patent/DK249389A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
  • Graft Or Block Polymers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK249389A 1988-05-24 1989-05-23 2-acylamino-benzothiazol-forbindelser og deres anvendelse til fremstilling af laegemidler til behandling af tumorer DK249389A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19803488A 1988-05-24 1988-05-24

Publications (2)

Publication Number Publication Date
DK249389D0 DK249389D0 (da) 1989-05-23
DK249389A true DK249389A (da) 1989-11-27

Family

ID=22731735

Family Applications (1)

Application Number Title Priority Date Filing Date
DK249389A DK249389A (da) 1988-05-24 1989-05-23 2-acylamino-benzothiazol-forbindelser og deres anvendelse til fremstilling af laegemidler til behandling af tumorer

Country Status (25)

Country Link
EP (1) EP0343893B1 (enExample)
JP (1) JPH0678331B2 (enExample)
KR (1) KR910006864B1 (enExample)
CN (1) CN1023700C (enExample)
AT (1) ATE79114T1 (enExample)
AU (1) AU601905B2 (enExample)
CA (1) CA1328871C (enExample)
DD (1) DD283815A5 (enExample)
DE (1) DE68902358T2 (enExample)
DK (1) DK249389A (enExample)
ES (1) ES2043012T3 (enExample)
FI (1) FI892498A7 (enExample)
GR (1) GR3005844T3 (enExample)
HU (1) HU202507B (enExample)
IE (1) IE891667L (enExample)
IL (1) IL90337A0 (enExample)
MX (1) MX173140B (enExample)
MY (1) MY106035A (enExample)
NO (1) NO172389C (enExample)
NZ (1) NZ229234A (enExample)
PL (1) PL154875B1 (enExample)
PT (1) PT90622B (enExample)
SU (1) SU1681728A3 (enExample)
YU (1) YU47019B (enExample)
ZA (1) ZA893862B (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2790299B2 (ja) * 1989-02-01 1998-08-27 保土谷化学工業株式会社 ペンゾチアゾール誘導体
US5262400A (en) * 1991-06-20 1993-11-16 Merck & Co., Inc. 4α-substituted avermectin derivatives
PL186370B1 (pl) * 1995-08-30 2003-12-31 Searle & Co Związki, pochodne kwasu aminobenzoesowego, zawierające je kompozycje farmaceutyczne oraz zastosowanie tych związków
US6100423A (en) * 1995-08-30 2000-08-08 G. D. Searle & Co. Amino benzenepropanoic acid compounds and derivatives thereof
US5716281A (en) * 1995-11-27 1998-02-10 Sega Enterprises, Ltd. Game apparatus using a vehicle with an optical image synthesizing system
TW513418B (en) * 1996-07-31 2002-12-11 Otsuka Pharma Co Ltd Thiazole derivatives, their production and use
NZ503491A (en) 1997-11-10 2002-08-28 Bristol Myers Squibb Co 2-substituted amino-1,3-benzothiazole derivatives useful as protein tyrosine kinase inhibitors
EP0928793B1 (en) * 1998-01-02 2002-05-15 F. Hoffmann-La Roche Ag Thiazole derivatives
WO1999052861A1 (de) * 1998-04-09 1999-10-21 Institut für Diagnostikforschung GmbH an der Freien Universität Berlin Neue benzylguanidinderivate für die therapie, in-vivo- und in-vitro-diagnostik
HRP20020962A2 (en) * 2000-06-21 2005-02-28 F. Hoffmann - La Roche Ag Benzothiazole derivatives
US6620811B2 (en) * 2001-11-19 2003-09-16 Hoffmann-La Roche Inc. Isonicotin- and nicotinamide derivatives of benzothiazoles
US6599901B1 (en) * 2001-11-19 2003-07-29 Hoffman-La Roche Inc. Pyridone substituted benzothiazole derivatives
US6624163B2 (en) * 2001-11-29 2003-09-23 Hoffman-La Roche Inc. Benzothiazole derivatives
GB0130868D0 (en) * 2001-12-24 2002-02-06 Univ Strathclyde New compounds
CN100357283C (zh) * 2002-04-02 2007-12-26 中国科学院上海药物研究所 一类甲硫氨酰氨肽酶抑制剂
US7087761B2 (en) 2003-01-07 2006-08-08 Hoffmann-La Roche Inc. Cyclization process for substituted benzothiazole derivatives
CN100372844C (zh) * 2003-05-13 2008-03-05 弗·哈夫曼-拉罗切有限公司 作为腺苷受体配体的2-咪唑-苯并噻唑
JP4444290B2 (ja) * 2003-05-19 2010-03-31 エフ．ホフマン−ラ ロシュ アーゲー アデノシン受容体リガンドとしてのベンゾチアゾール誘導体
BRPI0410754A (pt) * 2003-05-21 2006-06-27 Hoffmann La Roche derivados de benzotiazol e uso desses derivados no tratamento de doenças relacionadas com o receptor de adenosina a2a
AU2004243481B2 (en) * 2003-05-30 2008-10-09 F. Hoffmann-La Roche Ag Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine A2A receptor
BRPI0413072A (pt) * 2003-07-28 2006-10-03 Janssen Pharmaceutica Nv moduladores de lta4h
DE602005004142T2 (de) 2004-05-24 2009-01-02 F. Hoffmann-La Roche Ag 4-hydroxy-4-methylpiperidin-1-carbonsäure-(4-methoxy-7-morpholin-4-ylbenzothiazol-2-yl)-amid
CA2574193C (en) * 2004-07-22 2013-03-05 F. Hoffmann-La Roche Ag Benzothiazole derivatives as adenosine receptor ligands
RU2381227C2 (ru) * 2004-07-22 2010-02-10 Ф. Хоффманн-Ля Рош Аг Замещенные бензотиазолы
WO2006048172A1 (en) 2004-11-05 2006-05-11 F. Hoffmann-La Roche Ag Process for preparation of isonicotinic acid derivatives
DK1863818T3 (da) 2005-03-23 2010-05-10 Hoffmann La Roche Acetylenyl-pyrazolo-pyrimidinderivater som mglur2-antagonister
DE602006013493D1 (de) 2005-09-27 2010-05-20 Hoffmann La Roche Oxadiazolylpyrazolopyrimidine als mglur2-antagonisten
CN101405278A (zh) * 2006-03-15 2009-04-08 4Sc股份公司 新颖的杂环NF-κB抑制剂
GB0619325D0 (en) 2006-09-30 2006-11-08 Univ Strathclyde New compounds
WO2010008847A2 (en) * 2008-06-24 2010-01-21 Takeda Pharmaceutical Company Limited Pi3k/m tor inhibitors
US9499790B2 (en) 2010-08-26 2016-11-22 Kyoto University Method for promoting differentiation of pluripotent stem cells into cardiac muscle cells
KR20140070631A (ko) * 2011-09-30 2014-06-10 키네타, 인크. 항바이러스 화합물
KR101996343B1 (ko) 2012-01-27 2019-07-05 고쿠리츠 다이가쿠 호진 교토 다이가쿠 전능성 줄기세포의 심근분화 유도방법
US10196609B2 (en) 2013-03-08 2019-02-05 Kyoto University Composition for promoting cardiac differentiation of pluripotent stem cell comprising EGFR inhibitor
WO2015037706A1 (ja) * 2013-09-13 2015-03-19 国立大学法人京都大学 多能性幹細胞の心筋分化を促進する化合物
JP6651218B2 (ja) 2014-05-30 2020-02-19 国立大学法人京都大学 低分子化合物を用いた多能性幹細胞の心筋分化誘導法
CN109776486A (zh) * 2019-02-26 2019-05-21 武汉松石科技股份有限公司 一种硫酸亚丙酯的制备方法
CN110590735B (zh) * 2019-09-30 2021-07-23 江苏国泰超威新材料有限公司 一种环状硫酸酯的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61225168A (ja) * 1985-03-30 1986-10-06 Nippon Tokushu Noyaku Seizo Kk 新規ベンズアミド、その製法及び殺虫剤
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
GB8611606D0 (en) * 1986-05-13 1986-06-18 Fbc Ltd Fungicides

Also Published As

Publication number Publication date
HU202507B (en) 1991-03-28
JPH0217181A (ja) 1990-01-22
DK249389D0 (da) 1989-05-23
NO172389C (no) 1993-07-14
KR910006864B1 (ko) 1991-09-09
DE68902358T2 (de) 1992-12-10
YU105989A (en) 1990-08-31
IL90337A0 (en) 1989-12-15
CN1037898A (zh) 1989-12-13
NO892059L (no) 1989-11-27
MX173140B (es) 1994-02-02
AU601905B2 (en) 1990-09-20
ES2043012T3 (es) 1993-12-16
ATE79114T1 (de) 1992-08-15
IE891667L (en) 1989-11-24
KR890017248A (ko) 1989-12-15
NO892059D0 (no) 1989-05-23
ZA893862B (en) 1991-01-30
DD283815A5 (de) 1990-10-24
EP0343893B1 (en) 1992-08-05
HUT51606A (en) 1990-05-28
FI892498A0 (fi) 1989-05-23
SU1681728A3 (ru) 1991-09-30
NZ229234A (en) 1990-09-26
CN1023700C (zh) 1994-02-09
MX16158A (es) 1993-06-01
EP0343893A1 (en) 1989-11-29
DE68902358D1 (de) 1992-09-10
NO172389B (no) 1993-04-05
AU3509889A (en) 1989-11-30
FI892498A7 (fi) 1989-11-25
CA1328871C (en) 1994-04-26
MY106035A (en) 1995-03-31
YU47019B (sh) 1994-11-15
JPH0678331B2 (ja) 1994-10-05
GR3005844T3 (enExample) 1993-06-07
PT90622A (pt) 1989-11-30
PL279613A1 (en) 1989-11-27
PL154875B1 (en) 1991-09-30
PT90622B (pt) 1994-10-31

Similar Documents

Publication Publication Date Title
DK249389D0 (da) 2-acylamino-benzothiazol-forbindelser og deres anvendelse til fremstilling af laegemidler til behandling af tumorer
ES2071510T3 (es) Derivados de pirrolidina y de tiazolidina, su preparacion y los medicamentos que les contienen.
LU90944I2 (fr) Dérivés pipérazinyl-héterocycliques
NO169839C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alfa, alfa -(iminobis(metylen))bis(3,4-dihydro-2h-1-benzopyran-2-metanol)derivater
IT8848619A0 (it) Derivati di lisosfingolipidi
ES2056180T3 (es) Nuevos derivados de 2'-halometiliden, 2'-eteniliden y 2'-etinil citidina.
FI895447A7 (fi) Substituoidut terapeuttisina aineina käytettävät adeniinijohdannaiset
DK9987A (da) Ethanolaminderivater
FI884721A7 (fi) Fluorijohdannnaisten käyttö varjoaineina
IT1190405B (it) Derivati del flavone
FI93106C (fi) Menetelmä lääkeaineina käyttökelpoisten 2-iminobentsotiatsoliinijohdannaisten valmistamiseksi
KR920700625A (ko) 고혈압 치료를 위한 신장에 선택적인 프로드러그(Prodrug)
FI891986A7 (fi) Farmaseuttiset koostumukset psoriasiksen hoitoon
FI892222A0 (fi) Peptidalkoholer med antikoagulantverkan.
FI895983A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 2-bentsotiatsoliinijohdannaisten valmistamiseksi
DE68900760D1 (de) Virushemmende nukleosidmischung.
NO171847C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzenderivater
ES554903A0 (es) Disposicion para el tratamiento de piezas de trabajo
FI895977A7 (fi) 3,4-hydroksibentsoyloksipropanoliaminien esilääkeaine
IT1151104B (it) Impiego terapeutico di derivati (1-cinnamoil oppure 1-fenetil-carbonil)piperazinici
DK448288D0 (da) Ethanolaminderivater
DK415087A (da) Terapeutiske midler indeholdende benzhydrylthiomethanderivater
DK702188D0 (da) Ethanolaminderivater
FI915395A7 (fi) Melatoniinijohdosten käyttö hedelmöityksen ehkäisyyn
KR890701106A (ko) 과지혈증의 치료를 위한 옥소퀴나졸린 유도체의 용도